All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats

Zhiqing Zhong, Hongyan Li, Hongzhen Zhong, Wenshan Lin, Shujun Lin, Tian‐Biao ZhouRenal 2021 · DOI

TL;DR

This study investigates the role of all-trans retinoic acid (ATRA) in mitigating renal interstitial fibrosis (RIF) in rats. Researchers found that ATRA not only reduces fibrosis markers but also upregulates Angiopoietin-1 (Angpt-1), a protein previously linked to reduced fibrosis, suggesting ATRA's therapeutic potential for RIF by influencing Angpt-1 levels.

What Problem Does This Paper Address?

Renal interstitial fibrosis (RIF) is a critical pathological hallmark of chronic kidney disease (CKD) that often leads to end-stage renal disease and currently lacks effective treatments. A key feature of RIF is the excessive accumulation of extracellular matrix (ECM) in the kidney's interstitial space, driven by activated fibroblasts. While Angiopoietin-1 (Angpt-1) has been associated with reduced ECM accumulation and fibrosis, its specific role in RIF and its modulation by potential therapeutic agents like ATRA remained unclear. This paper aims to elucidate the relationship between ATRA, Angpt-1, and RIF, seeking to identify new therapeutic avenues for this debilitating condition.

Methods

The researchers employed a rat model of unilateral ureteral obstruction (UUO) to induce RIF. Rats were divided into three groups: sham (control), UUO (fibrosis model), and UUO treated with ATRA. Histological analysis, including Hematoxylin-eosin (H&E) and Masson trichrome staining, was used to assess the degree of renal damage and fibrosis. Immunohistochemistry and Western blotting were utilized to quantify the protein expression levels of key molecules: Angpt-1, transforming growth factor-beta 1 (TGF-β1), collagen IV (Col-IV), and fibronectin (FN). Statistical analysis, including one-way ANOVA and Pearson correlation, was performed to determine the significance of the findings and the relationships between different markers.

Datasets

Not discussed in the paper. The study utilized a rat model and collected tissue samples for analysis.

Key Insights and Ideas

  • Angpt-1 as a Protective Factor: The study strongly suggests that Angpt-1 acts as a protective factor against RIF. Its expression was significantly reduced in fibrotic kidneys, and its levels were negatively correlated with the severity of fibrosis and key ECM components.
  • ATRA's Dual Action: ATRA demonstrates a dual therapeutic effect: it directly reduces markers of fibrosis (TGF-β1, Col-IV, FN) and, importantly, it appears to restore or increase Angpt-1 expression in the fibrotic kidney. This suggests ATRA might work, at least in part, by modulating the Angpt-1 pathway.
  • Potential for Novel Therapies: The findings highlight ATRA as a promising candidate for RIF treatment, offering a potential mechanism of action that goes beyond simply suppressing fibrotic signals, by actively promoting a protective factor.

Key Results

  • UUO rats showed significantly increased RIF scores and elevated levels of TGF-β1, Col-IV, and FN compared to sham rats.
  • Conversely, Angpt-1 expression was significantly downregulated in UUO rats.
  • ATRA treatment markedly reduced RIF scores and the expression of TGF-β1, Col-IV, and FN in UUO rats.
  • Crucially, ATRA treatment significantly increased Angpt-1 expression in UUO rats.
  • A negative correlation was observed between Angpt-1 protein expression and RIF index, as well as the protein levels of Col-IV, FN, and TGF-β1 in UUO rat kidneys.

Limitations and Future Work

The authors acknowledge several limitations:

  • The study lacked a normal control group for comparison with the UUO group.
  • In vitro experiments using cell cultures to further explore ATRA's effect on Angpt-1 were not conducted.

Future work should focus on:

  • Confirming these findings in more comprehensive studies.
  • Investigating the precise molecular mechanisms by which ATRA influences Angpt-1 in the context of RIF.
  • Exploring the therapeutic potential of ATRA in other models of renal fibrosis.

Summary updated

Abstract

All-trans retinoic acid (ATRA) is one of essentially active metabolite of vitamin A, and plays an important role in diverse physiological processes, such as cellular growth and function. Renal interstitial fibrosis (RIF) is a common pathological characteristic of chronic renal disease causing end-stage renal disease currently lacking effective treatment. Low level of Angiopoietins-1 (Angpt-1) is associated with extracellular matrix accumulation and fibrosis diseases. This study was performed to assess the association of ATRA with Angpt-1 in RIF disease. Rats were divided into three groups: group of sham (SHO group), group of unilateral ureteral obstruction group (UUO group), UUO mice administrated daily at the dose of ATRA (ATRA group). Masson-staining was used to detect the histologic lesion. Immunohistochemistry and Western-blot were applied to determine the targeted proteins. RIF score was significantly increased in UUO rats when compared with that of SHO group, and the fibrosis score was notably reduced in ATRA group. Transforming growth factor-β1 (TGF-β1), collagen IV (Col-IV) and fibronectin (FN) expressions in UUO group were significantly up-regulated, whereas Angpt-1 expression was significantly down-regulated compared with the SHO group. ATRA treatment reduced TGF-β1, Col-IV and FN expressions and improved Angpt-1 expression compared with the UUO group. The protein expression of Angpt-1 in kidney tissue of UUO group was negatively correlated with RIF index and protein expressions of Col-IV, FN and TGF-β1. In conclusion, low expression of Angpt-1 was associated with the RIF disease and ATRA treatment can increase the Angpt-1 and alleviate the RIF lesion in UUO rats.
BibTeX
@inproceedings{zhong2021all,
  author = {Zhiqing Zhong and Hongyan Li and Hongzhen Zhong and Wenshan Lin and Shujun Lin and Tian‐Biao Zhou},
  title = {{All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats}},
  booktitle = {Renal},
  year = {2021},
  doi = {10.1080/0886022x.2021.1910046},
}
Figure